The days between OPD visits
Turning a condition plan into daily action, patient evidence and a better-prepared follow-up.
Editorial preview · OPD · adherence
A prescription or discharge plan defines intent. Continuity depends on what happens next: what the patient understood, what changed at home, what was completed, what evidence is missing and who owns the exception.
Explore the operating model →Latest from the journal
Browse the working editorial library. Every article must distinguish implemented workflow, approved design, platform vision and evidence still required.
Turning a condition plan into daily action, patient evidence and a better-prepared follow-up.
Editorial preview · OPD · adherence
Why recovery pathways need caregiver reality, routed concerns and documented closure.
Editorial preview · recovery · caregivers
How disease cores, medicines, comorbidities, nutrition and safety overlays interact.
Editorial preview · cores · overlays
Reason, owner, action and closure as the basic grammar of continuity operations.
Editorial preview · workflow · governance
Evidence readiness is more than a calendar reminder or an appointment notification.
Editorial preview · reports · next decision
Where instructions, medicines, function, nutrition and human support most often separate.
Editorial preview · evidence · escalation
A comorbidity or medicine context is useful only when it changes the permitted next action.
Editorial preview · medicines · safety
The operating model behind reasons, queues, human decisions and completed closure.
Editorial preview · triage · auditNo articles match this search.
Frequently asked
No. It is educational and product-operating content. Individual clinical decisions remain with the treating clinician.
No. Each article will label operational product truth, clinical design and future thinking clearly.
Yes. Use the Contact page to propose a care-continuity, condition or hospital-operations question.
Articles should distinguish intended operating advantages from proven clinical outcomes. Reduced admissions, complications or biomarkers must not be presented as established without prospective evidence.
Yes. Designed, in-development and future concepts should be identified clearly rather than described as universally available product functionality.